Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report
A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence....
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2011-01-01
|
| Series: | Clinical Medicine Insights: Oncology |
| Online Access: | https://doi.org/10.4137/CMO.S6525 |
| _version_ | 1828524093894295552 |
|---|---|
| author | Abhirami Vivekanandarajah Balakumar Krishnarasa Mervat Mourad Nelly Aoun Marcel Odaimi |
| author_facet | Abhirami Vivekanandarajah Balakumar Krishnarasa Mervat Mourad Nelly Aoun Marcel Odaimi |
| author_sort | Abhirami Vivekanandarajah |
| collection | DOAJ |
| description | A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence. He underwent re-resection with placement of carmustine impregnated wafers. Subsequently he had eighteen cycles of salvage biochemotherapy with bevacizumab and irinotecan. To date, routine MRI scans of the brain have not shown evidence of recurrence. He continues to be in remission three years after treatment with bevacizumab and irinotecan. |
| first_indexed | 2024-12-11T20:40:59Z |
| format | Article |
| id | doaj.art-75c730283abe47f0ba36958daaea8ac5 |
| institution | Directory Open Access Journal |
| issn | 1179-5549 |
| language | English |
| last_indexed | 2024-12-11T20:40:59Z |
| publishDate | 2011-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Clinical Medicine Insights: Oncology |
| spelling | doaj.art-75c730283abe47f0ba36958daaea8ac52022-12-22T00:51:31ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492011-01-01510.4137/CMO.S6525Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case ReportAbhirami Vivekanandarajah0Balakumar Krishnarasa1Mervat Mourad2Nelly Aoun3Marcel Odaimi4Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305.A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide. Before the completion of chemotherapy he had a recurrence. He underwent re-resection with placement of carmustine impregnated wafers. Subsequently he had eighteen cycles of salvage biochemotherapy with bevacizumab and irinotecan. To date, routine MRI scans of the brain have not shown evidence of recurrence. He continues to be in remission three years after treatment with bevacizumab and irinotecan.https://doi.org/10.4137/CMO.S6525 |
| spellingShingle | Abhirami Vivekanandarajah Balakumar Krishnarasa Mervat Mourad Nelly Aoun Marcel Odaimi Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report Clinical Medicine Insights: Oncology |
| title | Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report |
| title_full | Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report |
| title_fullStr | Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report |
| title_full_unstemmed | Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report |
| title_short | Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A case Report |
| title_sort | achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme a case report |
| url | https://doi.org/10.4137/CMO.S6525 |
| work_keys_str_mv | AT abhiramivivekanandarajah achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport AT balakumarkrishnarasa achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport AT mervatmourad achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport AT nellyaoun achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport AT marcelodaimi achievementofthreeyearremissionwithbevacizumabandirinotecaninrecurrentglioblastomamultiformeacasereport |